Testing effectiveness (Phase 2)Study completedNCT01075100What this trial is testingIxabepilone + Carboplatin Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer US Oncology Research 103
Large-scale testing (Phase 3)Ended earlyNCT01006252What this trial is testingTasisulam-sodium Versus Paclitaxel as Treatment for Metastatic MelanomaWho this might be right forMelanoma Eli Lilly and Company 336
Post-approval studies (Phase 4)Study completedNCT01064947What this trial is testingSafety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic DermatitisWho this might be right forAtopic DermatitisSecondary Infection Derm Research, PLLC 29
Not applicableStudy completedNCT03628417What this trial is testingConfirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous MetastasesWho this might be right forCutaneous Melanoma Szeged University 7
Not applicableEnrolling By InvitationNCT06388252What this trial is testingElectrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous MelanomaWho this might be right forCutaneous Malignant Melanoma Institute of Oncology Ljubljana 10
Testing effectiveness (Phase 2)Ended earlyNCT00581997What this trial is testingQAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic SclerosisWho this might be right forPulmonary Fibrosis Secondary to Systemic Sclerosis Novartis Pharmaceuticals 8
Testing effectiveness (Phase 2)UnknownNCT03412955What this trial is testingA Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and TaxanesWho this might be right forBreast Cancer Tan Tock Seng Hospital 14
Testing effectiveness (Phase 2)UnknownNCT00423397What this trial is testingGefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin CancerWho this might be right forNon-melanomatous Skin Cancer University of California, San Diego 16
Not applicableActive Not RecruitingNCT02401685What this trial is testingPOSNOC - A Trial Looking at Axillary Treatment in Early Breast CancerWho this might be right forBreast Cancer University Hospitals of Derby and Burton NHS Foundation Trust 1,900
Early research (Phase 1)Ended earlyNCT00479622What this trial is testingStudy of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Wyeth is now a wholly owned subsidiary of Pfizer 20
Testing effectiveness (Phase 2)Study completedNCT02259231What this trial is testingRTA 408 Capsules in Patients With Melanoma - REVEALWho this might be right forMelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma Biogen 41
Testing effectiveness (Phase 2)WithdrawnNCT00397501What this trial is testingBBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the BrainWho this might be right forBrain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT03009058What this trial is testingStudy of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable CancerWho this might be right forMetastatic Cancer Immodulon Therapeutics Ltd 2
Early research (Phase 1)Ended earlyNCT00977145What this trial is testingEvaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With MelanomaWho this might be right forMelanoma Craig L Slingluff, Jr 11
Early research (Phase 1)Ended earlyNCT01611675What this trial is testingLeflunomide+Vemurafenib in V600 Mutant Met. MelanomaWho this might be right forMelanoma Massachusetts General Hospital 3
Large-scale testing (Phase 3)Study completedNCT01216111What this trial is testingAdjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)Who this might be right forTriple Negative Breast Cancer Fudan University 647
Early research (Phase 1)Study completedNCT00514306What this trial is testingStudy of Intermittent OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 79
Not applicableUnknownNCT04137406What this trial is testingRole of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes MetastasisWho this might be right forBreast CancerLymph Node Metastases Peking University People's Hospital 160
Not applicableLooking for participantsNCT05573893What this trial is testingPROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab DeruxtecanWho this might be right forBreast NeoplasmsBreast CancerNeoplasm Metastasis AstraZeneca 800
Testing effectiveness (Phase 2)Study completedNCT00587964What this trial is testingPhase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesWho this might be right forBrain MetastasisBladder CancerBreast Cancer+10 more Memorial Sloan Kettering Cancer Center 51